International Travel Health Guide (9th Ed) - Hardcover

9780923947248: International Travel Health Guide (9th Ed)

Hardcover

ISBN 10: 0923947248 ISBN 13: 9780923947248

The 1998 International Travel HealthGuide, now with the assistance of Consulting Editors Dr. Jay Keystone and Dr. Phyllis Kozarsky, has been completely updated and expanded. In it, youll find information on new vaccines, as well as the latest information on malaria prevention and treatment, hepatitis, parasitic infections, jet lag, prevention and treatment of travelers diarrhea, fever in the returned travelerand much more. And if you are wondering what exotic illnesses and health hazards you might encounter on your trip, just turn to the World Medical Guide section of the HealthGuide for disease risk advisories on over 200 countries.

In short, the International Travel HealthGuide is a must for anyone concerned about safe travel. Whether you are traveling for business or pleasureor are a physician advising travelersthe International Travel HealthGuide should always be within easy reach to give you the essential information that you will needbefore, during, and even after your trip.

The 1998 International Travel HealthGuide is a significant departure from the previous editions. Drs. Jay Keystone and Phyllis Kozarsky, two of the most prominent authorities in the field of travel medicine, are now the Contributing Editors. They have meticulously reviewed the entire text of the 1998 edition. Our goal is to maintain the International Travel HealthGuide as the most accurate, user-friendly source of current travel-health information available, not only for lay travelers, but also for the thousands of health care providers who advise patients on how to stay healthy during travel. To help meet this goal, we have maintained the style and format of the HealthGuide, and kept the medicalese to a minimum, without sacrificing the quality of the information that a physician may need to diagnose or treat a number of infectious and tropical diseases.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

�ber die Autorin bzw. den Autor

Stuart Ramage Rose, M.D. is Director of the International Travel Clinic at Noble Hospital in Westfield, Massachusetts. He is a graduate of Amherst College and Columbia University, College of Physicians and Surgeons. He is board certified in both internal medicine and emergency medicine.

Dr. Rose is Founder and President of Travel Medicine, Inc. He is a member of the American Society of Tropical Medicine and Hygiene and the International Society of Travel Medicine.

Consulting Editors Jay Keystone, M.D. is Professor of Medicine at The University of Toronto, Director of International Health Programs, Faculty of Medicine and Director, International Medical Graduate Program, Ontario Ministry of Health. Dr. Keystone, is a world-recognized authority in the field of travel medicine.

Phyllis Kozarsky, M.D. is Associate Professor of Medicine at Emory where she is also Assistant Professor of International Health at the Emory University School of Public Health.

Dr. Kozarsky serves on the Executive Board of the International Society of Travel Medicine and is on the Editorial Board of both the American Journal of Tropical Medicine & Hygiene and the Journal of Travel Medicine. She is a consultant to the Division of Quarantine at the CDC as well as a consultant to numerous multinational corporations, missionary groups, and volunteer organizations.

Auszug. � Genehmigter Nachdruck. Alle Rechte vorbehalten.

World Medical Guide Section (Indonesia) Malaria: About one-half of the population is at risk of exposure, but relatively few travelers acquire the disease. There is no risk of malaria in the major metropolitan areas of Jakarta, Medan, Surabaya, and Yogyakarta and the main resort and tourist beach areas of Java and southern Bali. Malaria risk is primarily in rural areas below 1,200 meters elevation. The highest rates of malaria are in Irian Jaya (the western half of the island of New Guinea), Sulawesi, Sumatra, Flores, and the Kokap Subdistrict area of Java. In Java and Bali, Plasmodium vivax accounts for the majority of reported cases, whereas P. falciparum accounts for 30%50% of cases. Elsewhere, falciparum malaria predominates 2:1 over vivax malaria in mountainous regions. Chloroquine- and Fansidar-resistant P. falciparum are widespread. Chloroquine-resistant P. vivax occurs in a patchy distribution. It has been reported from Sumatra and Irian Jaya, but P. vivax appears to be still sensitive to chloroquine in Java and Lombok as of 1997. The recommended drug prophylaxis for adult travelers going to malarious areas is mefloquine, 250 mg weekly, or doxycycline, 100 mg daily. Chloroquine should not be used for the primary treatment of malaria.

��ber diesen Titel� kann sich auf eine andere Ausgabe dieses Titels beziehen.